Adaptimmune Therapeutics Plc (ADAP)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Norry Officer	$0.58	5,584	$3,243.19	7,510	2025-01-17	Filing
Lunger Officer	$0.58	5,584	$3,243.19	7,510	2025-01-17	Filing
Bertrand Officer	$0.58	5,584	$3,243.19	7,510	2025-01-17	Filing
Rawcliffe Officer, Director	$0.58	30,601	$17,773.06	44,327	2025-01-17	Filing
Rawcliffe Officer, Director	$0.57	29,096	$16,724.38	41,582	2025-01-15	Filing
Rawcliffe Officer, Director	$0.59	17,934	$10,543.40	25,711	2025-01-13	Filing
Rawcliffe Officer, Director	$0.59	12,539	$7,371.68	17,801	2025-01-13	Filing
Piccina Officer	$0.57	12,991	$7,467.23	18,421	2025-01-15	Filing
Norry Officer	$0.57	9,803	$5,634.76	13,756	2025-01-15	Filing
Norry Officer	$0.59	8,124	$4,776.10	11,516	2025-01-13	Filing
Norry Officer	$0.59	4,268	$2,509.16	5,845	2025-01-13	Filing
Lunger Officer	$0.57	9,803	$5,634.76	13,756	2025-01-15	Filing
Lunger Officer	$0.59	5,471	$3,216.40	7,623	2025-01-13	Filing
Lunger Officer	$0.59	4,268	$2,509.16	5,845	2025-01-13	Filing
Bertrand Officer	$0.57	9,803	$5,634.76	13,756	2025-01-15	Filing
Bertrand Officer	$0.59	5,471	$3,216.40	7,623	2025-01-13	Filing
Bertrand Officer	$0.59	4,268	$2,509.16	5,845	2025-01-13	Filing
Piccina Officer	$0.93	24,531	$22,813.83	38,293	2024-06-18	Filing
Rawcliffe Officer, Director	$0.67	30,080	$20,243.84	44,848	2024-01-17	Filing
Rawcliffe Officer, Director	$0.79	9,304	$7,350.16	14,104	2024-01-16	Filing